SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest.
Protein kinase D (PKD) has been implicated in many aspects of tumorigenesis and progression, and is an emerging molecular target for the development of anticancer therapy. Despite recent advancement in the development of potent and selective PKD small molecule inhibitors, the availability of in vivo...
Main Authors: | Manuj Tandon, Joseph M Salamoun, Evan J Carder, Elisa Farber, Shuping Xu, Fan Deng, Hua Tang, Peter Wipf, Q Jane Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4352033?pdf=render |
Similar Items
-
New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cells.
by: Manuj Tandon, et al.
Published: (2013-01-01) -
Evaluation of SD-208, a TGF-β-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma
by: Puran Fadakar, et al.
Published: (2016-06-01) -
Proliferation and arrest of human tetraploid cells
by: Kuffer, Christian
Published: (2015) -
Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208)
by: Abolfazl Akbari, et al.
Published: (2015-09-01) -
A targeted library screen reveals a new inhibitor scaffold for protein kinase D.
by: Manuj Tandon, et al.
Published: (2012-01-01)